Estimaciones de analistas de Wall Street para Biodesix, Inc. (BDSX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 6 |
| Mantener | 1 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 7 |
| Calificación media (1-5) | 0.86 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-02 | $-0.74 | ||
| 2026-08-05 | $-0.71 | $-0.90 | +21.3% |
| 2026-05-04 | $-0.81 | $-1.26 | +35.7% |
| 2026-02-26 | $-0.49 | $-1.05 | +53.3% |
| 2025-11-03 | $-1.16 | $-1.60 | +27.5% |
| 2025-08-07 | $-1.60 | $-1.40 | -14.3% |
| 2025-05-13 | $-1.60 | $-1.40 | -14.6% |
| 2025-03-03 | $-1.20 | $-0.07 | -1614.3% |
Ratios de valoración
| Precio / Valor contable | 32.11 |
| EV / EBITDA | -17.85 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | $20.4M | $24.6M | $45.6M | $54.5M | $38.2M | $49.1M | $71.3M | $88.5M |
| Coste de Ventas | $4.4M | $6.1M | $22.0M | $30.5M | $14.2M | $13.0M | $15.6M | $16.7M |
| Beneficio Bruto | $16.0M | $18.5M | $23.6M | $24.0M | $24.1M | $36.1M | $55.8M | $71.8M |
| I+D | $8.2M | $10.5M | $10.8M | $12.8M | $13.1M | $10.0M | $9.6M | $12.0M |
| Generales y Administrativos | $25.9M | $30.6M | $34.9M | $50.5M | $61.5M | $67.4M | $80.5M | $87.5M |
| Gastos Operativos | $34.1M | $45.2M | $46.5M | $64.9M | $74.6M | $77.4M | $90.2M | $99.5M |
| Beneficio Operativo | -$23.5M | -$26.7M | -$22.9M | -$40.9M | -$50.6M | -$41.3M | -$34.5M | -$27.8M |
| EBITDA | -$21.5M | -$24.9M | -$20.8M | -$35.5M | -$51.5M | -$37.1M | -$29.2M | -$21.9M |
| Gastos por Intereses | $2.9M | $3.0M | $7.6M | $4.5M | $8.1M | $9.5M | $8.3M | $7.7M |
| Beneficio Antes de Impuestos | -$26.2M | -$30.7M | -$31.4M | -$43.2M | -$65.4M | -$52.1M | -$42.9M | -$35.3M |
| Impuestos | $211000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$26.2M | -$30.7M | -$31.4M | -$43.2M | -$65.4M | -$52.1M | -$42.9M | -$35.3M |
| BPA | $-19.72 | $-2410.66 | $-23.61 | $-31.54 | $-31.09 | $-12.70 | $-6.62 | $-4.67 |
| BPA Diluido | $-19.72 | $-2410.66 | $-23.61 | $-31.54 | $-31.09 | $-12.70 | $-6.62 | $-4.67 |
| Acciones en Circulación (Diluidas) | $1.3M | $1.3M | $1.3M | $1.4M | $2.1M | $4.1M | $6.5M | $7.6M |
Precio
| Precio | $28.56 |
| Capitalización | $232M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ALGS · INMB · MRSN · NOTV · OKUR · PDSB · SKYE
Explorar sector: Healthcare · Medical - Diagnostics & Research
Más secciones de BDSX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones